Flexigroup Limited (ASX: FXL) – Stock Slumps on New Chief Executive Appointment

pci dss cloud computing

After putting three dedicated years of leadership in FXL group, Chief Executive Officer Symon Brewis- Weston decided to step down from the position with effect from 3 September 2018.

Following to Symon’s resignation Australia’s financial services giant Flexigroup Limited announced the appointment of Rebecca James as the Chief Executive Officer effective from 15 October 2018. Until then, Flexi Group’s Chief Financial Officer, Ross Aucutt is slated to take over the office of Chief executive.

Chief Marketing and Enterprise Officer of Prospa, an online lender, Rebecca James holds remarkable experience in financial services and consumer brand building. Previously, working with ME Bank she led the expansion of business from a mortgage originator to a full-service retail bank scaling the customer base up by 40%. Rebecca James also possess the exceptional 15 years of experience working with Australia’s largest independent customer base agency Lavender.

“Rebecca James is an extremely capable executive with significant financial services experience. The Board has been particularly impressed by her ability to create and commercialise innovative digital solutions in financial services which will be a key addition to Flexigroup’s skill base” stated FlexiGroup’s chairman, Andrew Abercrombie.

Thanking Symon Brewis-Weston the company acknowledges the growth in their Australian and New Zealand Card business under the term of his leadership.

Mr Abercrombie also confirms the appointment of Christine Christian as Deputy Chairman to the board of Flexigroup. However, Christine will continue in her role as Chair of the Board’s Risk and Compliance Committee, as informed by Mr Abercrombie in the announcement of board appointment.

Sponsored ad by Kalkine

Following to the recent update, FXL stock fell by 13.07% to $1.982 on August 06, 2018, before market close.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Facebook Comments

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here